Dr Agarwals Eye Hospital Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals

Technical Trend Shift and Price Movement

The stock of Dr Agarwals Eye Hospital Ltd (NSE: 718153) closed at ₹4,786.20 on 5 Feb 2026, marking a 2.34% increase from the previous close of ₹4,676.95. The intraday range was relatively tight, with a low of ₹4,700.20 and a high of ₹4,825.00, indicating controlled buying interest. This price action reflects a mild bullish momentum after a period of sideways consolidation.

Over the past week, the stock outperformed the Sensex, delivering a 2.80% return compared to the benchmark’s 1.79%. However, the one-month and year-to-date returns remain negative at -12.34% and -10.28% respectively, underperforming the Sensex’s -2.27% and -1.65% in the same periods. This divergence highlights short-term volatility amid a longer-term recovery phase.

MACD and Momentum Oscillators Paint a Mixed Picture

The Moving Average Convergence Divergence (MACD) indicator, a key momentum gauge, remains mildly bearish on both weekly and monthly timeframes. This suggests that while short-term momentum is improving, the broader trend has yet to confirm a sustained uptrend. The MACD histogram on the weekly chart shows a slight contraction in negative momentum, hinting at a potential turnaround if buying pressure continues.

Conversely, the Relative Strength Index (RSI) offers a more optimistic view. The monthly RSI has shifted into bullish territory, signalling that the stock is gaining strength over the longer term. The weekly RSI, however, remains neutral with no clear signal, reflecting the stock’s recent sideways movement. This divergence between weekly and monthly RSI underscores the importance of monitoring multiple timeframes for a comprehensive technical assessment.

Moving Averages and Bollinger Bands Indicate Mild Bullishness

Daily moving averages have turned mildly bullish, with the stock price currently trading above its short-term averages. This crossover often acts as an early indicator of upward momentum, attracting technical traders. Meanwhile, Bollinger Bands present a nuanced view: weekly bands remain mildly bearish, suggesting some resistance and volatility in the near term, whereas monthly bands have turned bullish, indicating expanding price range and potential for upward breakout over the medium term.

Other Technical Indicators and Market Sentiment

The Know Sure Thing (KST) oscillator, which aggregates multiple momentum indicators, remains mildly bearish on both weekly and monthly charts. This aligns with the MACD’s cautious stance and suggests that momentum has not fully shifted to the bulls. Dow Theory analysis shows no clear trend on weekly or monthly scales, reinforcing the notion of a market in transition rather than a confirmed directional move.

On-balance volume (OBV) data is currently inconclusive, lacking a definitive trend signal. This absence of strong volume confirmation means that price moves should be interpreted with caution, as they may not be fully supported by institutional buying or selling.

Long-Term Performance and Market Capitalisation Context

Dr Agarwals Eye Hospital Ltd has demonstrated exceptional long-term returns, significantly outpacing the Sensex over 3, 5, and 10-year horizons. The stock has delivered a staggering 402.88% return over three years, compared to the Sensex’s 37.76%, and an impressive 1,173.09% over five years against the benchmark’s 65.60%. Over a decade, the stock’s return of 1,910.16% dwarfs the Sensex’s 244.38%, underscoring its strong growth trajectory within the hospital sector.

Despite this, the current MarketsMOJO Mojo Score stands at 61.0 with a Mojo Grade of Hold, upgraded from Sell on 29 Aug 2025. The market cap grade is a modest 3, reflecting a mid-sized valuation relative to peers. This rating suggests that while the stock has growth potential, investors should exercise caution given recent volatility and mixed technical signals.

Valuation and Price Range Analysis

The stock’s 52-week high is ₹6,392.00, while the low stands at ₹3,500.00, indicating a wide trading range and significant price swings over the past year. The current price of ₹4,786.20 sits closer to the lower half of this range, suggesting room for upside if bullish momentum sustains. However, the recent one-month and year-to-date negative returns highlight the need for careful entry timing.

Sector and Industry Considerations

Operating within the hospital sector, Dr Agarwals Eye Hospital Ltd benefits from structural growth drivers such as increasing healthcare demand and rising eye care awareness in India. However, sector-specific risks including regulatory changes, competition, and cost pressures remain pertinent. The stock’s technical indicators reflect this balance, with cautious optimism tempered by some bearish momentum signals.

Investor Takeaway and Outlook

For investors analysing Dr Agarwals Eye Hospital Ltd, the current mildly bullish daily moving averages combined with a bullish monthly RSI provide encouraging signs of a potential upward trend. However, the mildly bearish MACD and KST on weekly and monthly charts counsel prudence, indicating that the stock has not yet fully confirmed a sustained rally.

Given the stock’s strong long-term performance and recent upgrade from Sell to Hold by MarketsMOJO, investors may consider a measured approach, monitoring key technical levels and volume confirmation before committing significant capital. The stock’s proximity to the lower end of its 52-week range offers an attractive entry point for those with a medium to long-term horizon, provided broader market conditions remain supportive.

In summary, Dr Agarwals Eye Hospital Ltd is transitioning from a sideways phase to a cautiously optimistic stance, with technical indicators signalling a tentative shift towards bullish momentum. Investors should weigh these mixed signals alongside fundamental factors and sector dynamics to make informed decisions.

Unlock special upgrade rates for a limited period. Start Saving Now →